Osaka, Japan

Akiko Takada

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Takada. Retrieved from https://idiyas.com/inventor/akiko-takada-ipp4a86r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akiko Takada: Innovator in Pharmaceutical Preparations

Introduction

Akiko Takada is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the stability and purity of pharmaceutical preparations.

Latest Patents

Akiko Takada holds a patent for a mirabegron-containing tablet, which includes a method for producing a mirabegron-containing pharmaceutical preparation and a method for producing a mirabegron-containing granulated product. This invention aims to provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Additionally, it ensures that the purity of mirabegron is preserved while preventing the generation of related substances during storage. The pharmaceutical preparation includes mirabegron, hypromellose, and polyvinylpyrrolidone, and may contain a spray-dried granulated product.

Career Highlights

Akiko Takada is associated with Sawai Pharmaceutical Co., Ltd., where she has been instrumental in advancing pharmaceutical technologies. Her innovative approach has led to the development of formulations that improve drug stability and efficacy.

Collaborations

Throughout her career, Akiko has collaborated with notable colleagues, including Toshihiro Yanagi and Kenji Nozawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Akiko Takada's contributions to the pharmaceutical industry exemplify her commitment to innovation and excellence. Her work not only enhances drug formulations but also sets a standard for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…